Regulatory readiness Small-to-mid size pharma and device companies often struggle with GxP compliance, inspections, and regulatory submissions. GPD Solutions presents a targeted opportunity to upsell comprehensive quality systems development, validation services, and audit readiness programs to firms striving for smoother FDA/EMA/Health Canada inspections.

Validation expertise The firm’s strong emphasis on full lifecycle validation for equipment, processes, cleanrooms, utilities, and computerized systems positions it to win engagements with manufacturers expanding manufacturing capacity or upgrading facilities who need robust IQ/OQ/PQ execution and documentation.

Clinical trial support GPD Solutions offers end-to-end clinical trial support from protocol development to monitoring and closeout, presenting cross-sell potential to biotech clients planning early- to late-phase studies seeking CRO-like regulatory alignment and GCP compliance without adding headcount.

Audit and risk focus The emphasis on internal and supplier audits, mock inspections, and CAPA-driven risk management aligns with mid-market manufacturers facing supplier quality risks and potential FDA 483s, creating opportunities for ongoing compliance programs and corrective action services.

Compact expert team With a small team serving a global standards landscape, there is potential to position GPD as a cost-effective, high-touch partner for startups and small manufacturers seeking senior-level regulatory guidance, training, and rapid deployment of quality systems without large fixed costs.